<DOC>
	<DOCNO>NCT00174694</DOCNO>
	<brief_summary>Primary objective : - To demonstrate clinical efficacy telithromycin ( 800 mg od 5 day ) non-inferior amoxicillin-clavulanic acid ( 875/125 mg bid 10 day ) test-of-cure ( TOC ) visit ( Day 17-21 ) subject acute bacterial sinusitis ( ABS ) . Secondary objective ( ) : - To assess time resolution sign symptom baseline ( Day 1 ) TOC ( Day 17-21 ) visit , - To assess rate clinical relapse follow-up visit ( Day 41-49 ) , - To assess health economic outcome follow-up visit ( Day 41-49 ) , - To assess quality life follow-up visit ( Day 41-49 ) , - To compare safety telithromycin amoxicillin-clavulanic acid , - To compare bacteriologic outcome treatment observe TOC ( Day 17-21 ) follow-up visit ( Day 41-49 ) , subject ABS .</brief_summary>
	<brief_title>CHOOSE : Telithromycin , Acute Bacterial Sinusitis</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Telithromycin</mesh_term>
	<criteria>Non pregnant female Outpatients clinical diagnosis ABS , base presence : Signs symptom last longer 7 day less 28 day , Purulent anterior posterior nasal discharge One additional major sign symptom 2 minor sign symptom . The major minor sign symptom define follow : Major sign symptom : facial pain/pressure/tightness maxillary sinus , nasal congestion/obstruction , change perception smell ( hypoanosmia/anosmia ) , fever ( temperature &gt; 38° C [ 100.4 F ] ( oral ) / &gt; 38.5° C [ 101.2 F ] ( tympanic ) / &gt; 39° C [ 102.2 F ] ( rectal ) ) , Minor sign symptom : headache , halitosis , dental pain , ear pressure/fullness , cough , fatigue , Subjects abnormal maxillary sinus xrays ( Waters view additional view necessary ) limit sinus CT scan sinus ultrasound previous 48 hour inclusion define presence least 1 follow homolateral radiological criterion : Presence air/fluid level , Total opacification , Mucosal thicken &gt; 10 mm , Written inform consent must obtain enrollment study subject . Related disease : History recurrent sinusitis ( ( &gt; ) 3 episode sinusitis require antibiotic therapy within previous 12 month ) , Chronic sinusitis ( sign symptom last 28 day ) , Suspicion sinusitis require treatment oral antibiotic therapy , Suspicion concomitant odontologic infection , require antibiotic therapy surgery Nosocomial sinusitis ( eg , hospitalization 48 hour non ambulatory institutional confinement include nursing home within 2 week ) , Known major obstructive anatomic/functional lesion nasopharynx : anatomical blockage ( eg , chronic nasal polyp , severely deviated septum ) , cystic fibrosis , immotile cilium , sinus polyp , Use nasal , nasogastric nasotracheal catheter , Sinus puncture and/or sinus lavage previous 7 day , Previous sinus surgery last 6 month , Maxillary sinusitis require immediate surgery Symptomatic allergic sinusitis and/or allergic rhinitis , Exposition environmental irritant workplace Related previous/concomitant medication : Previous treatment intranasal , oral parenteral antibiotic ( 24 hour intake ) within 30 day prior enrollment , Intranasal corticosteroid short term systemic corticosteroid use within past 10 day prior enrollment , Maintenance systemic corticosteroid therapy inclusion ( &gt; 10 mg/day equivalent prednisone ) , Subjects longterm user ( &gt; 4 week ) nasal decongestant like oxymetazoline 0.05 % , Required ontherapy contraindicate medication study treatment ( accord country label ) : ergot alkaloid derivative ( ergotamine dihydroergotamine ) , cisapride , pimozide , astemizole , terfenadine , simvastatin , atorvastatin lovastatin , allopurinol , methotrexate , probenecid , Previous treatment within 2 week enrollment study medication rifampicin , phenytoin , carbamazepine , StJohn'swort , phenobarbital , Treatment investigational product last 30 day study entry . Other exclusion criterion Subject mononucleosis , phenylketonuria , Immunocompromised subject , : subject know HIV subject either AIDSdefining condition ( eg , Kaposi 's sarcoma , Pneumocystis carinii pneumonia ) CD4+ Tlymphocyte count &lt; 200/mm3 , know neutropenia ( &lt; 1500 neutrophils/mm3 ) attributable acute infectious disease , metastatic hematological malignancy , splenectomized know hyposplenia asplenia , History congenital family history long QT syndrome ( exclude previous ECG ) , Subjects know acquire QT interval prolongation , Subjects myasthenia gravis , Subjects galactose intolerance , Subjects progressively fatal disease , life expectancy £ 3 month , Women breastfeed pregnant childbearing potential ( ie , ovulate , premenopausal , surgically sterile ) fail use adequate contraception example systemic hormone ( birth control pill , implant ) , intrauterine device barrier method ( diaphragm intravaginal spermicide , cervical cap , male female condom ) . A urine serum test carry enrollment study , History know hypersensitivity and/or adverse reaction telithromycin macrolides , amoxycillinclavulanic acid betalactams , Clinically relevant cardiovascular , hepatic , neurologic , endocrine , major systemic disease make implementation protocol interpretation study result difficult , History drug alcohol abuse render subject unable comply protocol , Known history severe impaired renal function , show previous laboratory value creatinine clearance ≤ 30 ml/min either measure estimate Cockroft formula serum creatinine &gt; =2.0 mg/dL ( &gt; =176 μmol/L ) , Mental condition render subject unable understand nature , scope , possible consequence study , Subjects unlikely adhere protocol , eg , uncooperative attitude , inability return followup visit , unlikelihood completing study , Subject investigator subinvestigator , research assistant , pharmacist , study coordinator , staff relative thereof involve conduct protocol , Subjects already include study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>